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INTRODUCTION
Adenosine triphosphate-sensitive potassium (KATP)
channels are widely distributed in various tissues,
and respond to changes in the cell metabolism (1).
In vascular smooth muscle cells, the opening of KATP
channels causes vasodilation under physiological
and pathophysiological conditions (2).
Nicorandil is a KATP channel opener with nitrate-
like properties used in the management of angina
pectoris (3, 4). Furthermore, a recent prospective
randomized multicenter study demonstrated that
prophylactic administration of nicorandil during
operation reduced the frequency of cardiac events
in patients undergoing noncardiac surgery (5). How-
ever, our previous studies have indicated that in-
travenous anesthetics, including ketamine directly
inhibited KATP channel activities (6 - 8). Thus, it is
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important to understand whether significant interac-
tions might occur between nicorandil and intrave-
nous anesthetics when both drugs are adminis-
trated concurrently.
KATP channels are regulated by changes in intra-
cellular ATP and ADP concentrations (1). Previous
studies on native KATP channels have suggested that
nicorandil action is also dependent on the presence
of MgADP (9, 10). But whether the action of keta-
mine on nicorandil induced KATP channels depends
on the presence of MgADP is currently unknown.
In the current study, we used patch clamp tech-
niques to examine the electrophysiological effects
of ketamine on nicorandil induced KATP channel ac-
tivity in cultured rat aortic smooth muscle cells. We




A continuous line of A10 vascular smooth muscle
cells, derived from the thoracic aorta of fetal rats, was
obtained from the American Type Culture Collec-
tion (ATCC). The cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10%
fetal bovine serum (Life Technologies, Invitrogen,
Carlsbad, CA, USA), 3.7 mg ml-1 NaHCO3, and 100
μg ml-1 gentamycin at 37in a humidified atmos-
phere of 95% air and 5% CO2. The medium was
changed initially after 48 h and then every 2-3 days.
When the cells had formed a confluent monolayer
after 7-9 days, they were rendered quiescent by in-
cubation in serum- free medium for 24 h and then
harvested by the addition of 0.05% trypsin and 0.1%
fetal bovine serum. Cells were used for experiment
after 12 passages.
Electrophysiological analysis
Channel currents were recorded with a patch
clamp amplifier (CEZ 2200 ; Nihon Kohden, Tokyo,
Japan) and stored in a personal computer (Aptiva ; In-
ternational Business Machine Corporation, Armonk,
NY, USA) with an analogue-to-digital converter
(DigiData 1200 ; Axon Instruments, Foster City, CA,
USA). pClamp version 7 software (Axon Instru-
ments, Foster City, CA, USA) was used for data ac-
quisition and analysis.
Electrophysiological measurements
Single channel currents were recorded in the
inside-out configurations using a patch clamp am-
plifier as described previously (6-8). The intracel-
lular solution contained 140 mM KCl, 2 mM EGTA,
2 mMMgCl2, and 10 mM HEPES (pH=7.3). The pi-
pette solution contained 140 mM KCl, 1 mM CaCl2,
1 mM MgCl2, and 10 mM HEPES (pH=7.4). Patch
pipettes were pulled with an electrode puller (PP-
830 ; Narishige, Tokyo, Japan). Recordings were
made at 360.5. The resistance of pipettes filled
with internal solution and immersed in Tyrode’s so-
lution was 5-7 MΩ. The sampling frequency of the
single-channel data was 5 KHz with a low-pass fil-
ter (1 KHz). The open probability (Po) was deter-
mined from current amplitude histograms and was







where tj is the time spent at current levels corre-
sponding to j=0, 1, 2, N channels in the open state ;
Td is the duration of the recording ; and N is the
number of the channels active in the patch. Record-
ings of 1-2 min were analyzed to determine Po. The
channel activity was expressed as NPo. The NPo in
the presence of drugs was normalized to the base-
line NPo value obtained before drug administration
and presented as relative channel activity.
Superfusates were directly applied to cells in the
glass-bottom plastic cell bath (2-ml volume) at a
rate of 2-2.5 ml/min using a plastic syringe (50-ml
volume), vinyl chloride tubing (0.8-mm ID ; 50-cm
length), and syringe pump (Terumo STC-525 ;
Tokyo, Japan). When the concentration-dependent
effects of drugs were studied, the superfusion was
stopped for approximately 1 min at each concentra-
tion, and these drugs were injected into the cell
bath using a glass syringe to five final concentra-
tions in a cumulative manner (total volume injected
was approximately 10-20 μl). Thus, the superfusion
was stopped for total of approximately 5 min, and
preliminary studies showed that stopping superfu-
sion for approximately 5 min had no significant
effects on electrophysiological measurements. The
drug concentration needed to induce half-maximal
inhibition of the channels (IC50) and the Hill coeffi-




where y is the relative NPo, [D] is the concentration
of drug, Ki is the IC50, and H is the Hill coefficient.
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Statistics
All data are presented as meansSE. Repeated-
measures analysis of variance, followed by the Stu-
dent-Newman-Keuls test, was applied to identify
significant differences among the effects observed
with different concentrations of ketamine racemate
or S-(+)-ketamine. Paired statistical comparisons
were made using paired t tests. In all comparisons,
P0.05 was considered significant.
Drugs
Ketamine racemate, S-(+)-ketamine, glibencla-
mide, and nicorandil were obtained from Sigma-
Aldrich Japan (Tokyo, Japan). Glibenclamide and
nicorandil were dissolved in dimethylsulfoxide
(DMSO, the final concentration of solvent in the
cell bath was 0.01%). Preliminary studies showed
that 0.02% of DMSO, a 2-fold higher concentration
than used in the present study, had no significant
effects on cultured rat aortic smooth muscle KATP
channel currents.
RESULTS
Nicorandil induced KATP channel activities in A10
cell derived from rat aortic smooth muscle
The effects of nicorandil on KATP channel in in-
side-out patch clamp configuration were recorded
(Figure 1A). Single channel activities were observed
infrequently before treatment of nicorandil (NPo
Figure 1. Shingle-channel characteristics of adenosine triphosphate-sensitive potassium channels in inside-out patch clamp configu-
ration. (A) Representative traces of channel currents recorded from A10 cells are shown. Membrane potentials were clamped at -60
mV. Nicorandil (100 μM) and glibenclamide (0.5 μM) were added to the intracellular solution as indicated by the horizontal bar. C,
closed channel level ; O1 and O2, open channel levels with one or two channels open simultaneously, respectively. Amplitude histo-
grams were plotted by binning the data from the original recordings. The relative peaks of the histogram indicate the periods the
channel resides in each conductance level. (B) The relationship between NPo and time after application of nicorandil (100 μM, left
panel) and no application of nicorandil (time control, right panel). Each vertical bar represents measurements from 12 patches
(meanSE). * p0.05 versus baseline.
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0.001, n=10). Application of 100 μM nicorandil to
the bath solution (intracellular side) significantly acti-
vated K+-selective channel activities. These channel
activities were completely blocked by 0.5 μM gliben-
clamide, a specific KATP channel inhibitor (Figure 1A,
n=10), suggesting that the activity is indeed due to
KATP channel currents. Figure 1B shows the relation-
ship between nicorandil-induced NPo values and
time for the traces. Approximately 4-5 min after ap-
plication of 100 μM nicorandil, NPo reached steady-
state (0.260.02, n=10). Identical control experi-
ments in the absence of nicorandil resulted in no
KATP channel activation or inhibition during the same
time periods (Figure 1B, n=5). In addition, the sin-
gle channel conductance was 29.41.2 pS (Figure 2,
n=17), as measured by the current-voltage relation-
ship between -80 and +60 mV membrane potential
under conditions of symmetrical 145 mM K+.
Effects of ketamine racemate on nicorandil induced
KATP channel activities
To assess the effects of ketamine on nicorandil
induced KATP channel activities in the absence of in-
tracellular ADP, we measured single channel cur-
rents on inside-out patches in the presence of keta-
mine racemate. Application of 1-1000 μM ketamine
racemate to the intracellular membrane surface in-
hibited the nicorandil induced KATP channel currents
in a dose dependent-manner. As indicated in Figure
3A the inhibitory effects of ketamine racemate on
KATP channel activities were readily reversible.
The dose-dependent effects of ketamine racemate
on nicorandil induced KATP channel activities in the
absence of intracellular ADP are shown in Figure
3B. The IC50 and Hill coefficient (h) of ketamine
racemate for the KATP channels are 341 μM and
0.93 (n=14), respectively. The average percent re-
covery of KATP channel activities after washout of
ketamine racemate was 922% of the NPo meas-
ured before drug treatment.
Effects of S-(+)-ketamine on nicorandil induced
KATP channel activities
In contrast to ketamine racemate, S-(+)-ketamine
at 1-30 μM did not significantly inhibit nicorandil
induced KATP channel currents (Figure 4A, n=11),
indicating that the inhibitory effect of ketamine on
Figure 2. The current-voltage relationship for adenosine
triphosphate-sensitive potassium channel currents. Each verti-
cal bar represents measurements from 17 patches (meanSE).
Figure 3. Effects of ketamine racemate on nicorandil induced
adenosine triphosphate-sensitive potassium channel currents in
the inside-out patch clamp configuration. (A) Representative ex-
ample of nicorandil induced channel currents obtained before
and after the application of ketamine racemate (1-1000 μM) is
shown. Nicorandil (100 μM) and ketamine racemate were added
to the intracellular solution as indicated by the horizontal bar. C,
closed channel level ; O1 and O2, open channel levels with one
or two channels open simultaneously, respectively. (B) Dose-
dependent effects of ketamine racemate on the nicorandil induced
channel activities. Each vertical bar constitutes measurements
from 14 patches (meanSE). *p0.05 versus baseline.
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nicorandil induced KATP channel activities may be
stereoselective.
The dose-dependent effects of S-(+)-ketamine on
nicorandil induced KATP channel activities in the ab-
sence of intracellular ADP are shown in Figure 4B.
The IC50 and Hill coefficient (h) of S-(+)-ketamine
for the nicorandil induced KATP channels are 2267
μM and 1.01 (n=10), respectively. The average per-
cent recovery of KATP channel activities after wash-
out of S-(+)-ketamine was 943% of the NPo meas-
ured before drug treatment.
Effects of ketamine racemate on nicorandil induced
KATP channel activities in the presence of intracel-
lular ADP
Recent studies have demonstrated that the ef-
fects of KATP channel agonists (9, 10) and ketamine
racemate (8) on KATP channels are modified by in-
teraction of MgADP with sulphonylurea receptors
(SURs). Therefore, we next examined whether the
inhibitory effects of ketamine racemate on nicorandil
induced KATP channel currents in rat aortic smooth
muscle cells are affected by the presence of intra-
cellular MgADP.
Figure 5A and 5B shows the effects of 30 μM
ketamine racemate on nicorandil induced KATP chan-
nel activities in the absence or presence of a physi-
ological concentration of MgADP (100 μM). Appli-
cation of MgADP to the intracellular side of the
channels significantly reduced the ketamine race-
mate inhibition of nicorandil induced KATP channel
activities. In addition, the inhibitory potency of keta-
mine racemate on nicorandil induced KATP channel
Figure 4. Effects of S-(+) -ketamine on nicorandil induced
adenosine triphosphate-sensitive potassium channel currents in
the inside-out patch clamp configuration. (A) A representative
example of nicorandil induced channel currents obtained before
and after the application of S-(+) -ketamine (1-1000 μM) is
shown. Nicorandil (100 μM) and S-(+) -ketamine were added to
the intracellular solution as indicated by the horizontal bar. C,
closed channel level ; O1 and O2, open channel levels with one
or two channels open simultaneously, respectively. (B) Dose-
dependent effects of S-(+) -ketamine on the nicorandil induced
channel activities. Each vertical bar constitutes measurements
from 14 patches (meanSE). *p0.05 versus baseline.
Figure 5. Effects of ketamine racemate and MgADP on nicoran-
dil induced adenosine triphosphate-sensitive potassium channels
in the excised inside-out configuration. (A) Representative ex-
ample of nicorandil induced channel currents in the absence or
presence of ketamine racemate and MgADP is shown. Nicoran-
dil (100 μM), ketamine racemate (30 μM) and MgADP (100 μM)
were added to the intracellular solution as indicated by horizontal
bars. C, closed channel level ; O1 and O2, open channel levels
with one or two channels open simultaneously, respectively.
(B) The relative channel activities in the presence of ketamine
racemate without MgADP (open columns) or with MgADP
(closed columns). The horizontal bars indicate the meanSE
(n=12), respectively. *p0.05 versus without MgADP value.
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activities was attenuated in the presence of intra-
cellular MgADP (Figure 6A and 6B) ; ketamine ra-
cemate significantly inhibited nicorandil induced
KATP channel activities only at the highest concen-
tration (1000 μM, n=8, p0.05 vs. baseline).
DISCUSSION
In the present study, we recorded single KATP
channel currents using an inside-out patch clamp
configuration and demonstrated that ketamine ra-
cemate and S-(+)-ketamine inhibited these channel
activities induced by nicorandil in a concentration-
dependent manner. Furthermore, the inhibitory ef-
fects of ketamine racemate had approximately 7-
fold higher potency than those of S-(+)-ketamine.
Since ketamine racemate is a mixture of S-(+) and
R-(-)-ketamine stereoisomers, this observation
would suggest that block of KATP channels by keta-
mine enantiomers may be at least partly stereose-
lective. Our results also demonstrated that intracellu-
lar MgADP restored the inhibitory action of keta-
mine racemate on nicorandil induced KATP channel
activities.
KATP channels, which are widely distributed in
many tissues, respond to alterations in the metabolic
activity of the cell and thereby act as sensors of glu-
cose and oxygen availability (1, 11). In the cardio-
vascular system, the sarcolemmal KATP channels are
present both in cardiomyocytes and vascular smooth
muscle cells (1). Recent physiological studies on
mice lacking different KATP channel subunits have
begun to clarify the roles of cardiac and vascular
KATP channels in cardiovascular pathophysiology.
Cardiac KATP channel (Kir6.2-/ -)-deficient mice had
a number of cardiac abnormalities during myocar-
dial ischemia or severe stress, including impaired
ischemic preconditioning and attenuated electro-
cardiographic ST changes (12). Impaired vascular
smooth muscle function was a feature of Kir6.1-
deficient and SUR2-deficient mice and manifested
as episodic coronary artery vasospasm and a high
rate of sudden death (13, 14). Nicorandil is a po-
tent cardiac and vascular KATP channel opener (9).
In clinical practice, therefore, this drug is widely
used in the treatment of ischemic heart disease (4).
A recent study further suggested that prophylactic
administration of nicorandil proved useful in the pe-
rioperative prevention of cardiac complications (5).
Our previous study demonstrated that ketamine
racemate directly inhibited sarcolemmal KATP chan-
nels that formed by subunits expressed in COS-7
cells (8). The present study indicates that ketamine
racemate also inhibits nicorandil induced KATP chan-
nel activities in native vascular smooth muscle cells
(VSMCs). During surgical anaesthesia, clinical
plasma concentrations for ketamine racemate are
20-50 μM, with approximately 12% of the drug be-
ing bound to plasma proteins (15). In current study,
the threshold concentrations of ketamine racemate
which inhibits nicorandil induced KATP channel ac-
tivities (10 μM) are within this range, but the con-
centrations of S-(+)-ketamine required for inhibi-
tion were very high (100 μM). It is likely, there-
fore, that ketamine racemate inhibits KATP channel
activities induced by nicorandil at clinically relevant
concentrations. These results suggested that keta-
mine racemate could impair nicorandil induced phar-
macological organ-protection against intraoperative
Figure 6. Effects of ketamine racemate on nicorandil induced
adenosine triphosphate-sensitive potassium channels in the ex-
cised inside-out configuration under intracellular MgADP con-
taining condition. (A) Representative example of nicorandil and
MgADP induced channel currents before and after the applica-
tion of ketamine racemate is shown. Nicorandil (100 μM) with
MgADP (100 μM) and ketamine racemate (1-1000 μM) were
added to the intracellular solution as indicated by horizontal bars.
C, closed channel level ; O1 and O2, open channel levels with
one or two channels open simultaneously, respectively. (B) Dose-
dependent effects of ketamine racemate on the nicorandil induced
channel activities in the presence of MgADP. Each vertical bar
constitutes measurements from 8 patches (meanSE). *p0.05
versus baseline.
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ischemic or hypoxic injury mediated by KATP chan-
nels. Indeed, racemic ketamine, but not the S-(+)-
ketamine stereoisomer, was found to block early
and late preconditioning in rabbit hearts (16, 17)
and inhibit vasorelaxation induced by a KATP chan-
nel opener, levocromakalim (18).
A previous study reported that acute ischemic pre-
conditioning in the rabbit heart is observed with
nicorandil treatment prior to ischemia, but not after
myocardial ischemia (19). These results indicate
that activation of KATP channels during metabolic
stress is essential for pharmacological organ pro-
tective effects of nicorandil.
During metabolic stress such as hypoxia or ische-
mia, the concentration of intracellular ADP rises
while the levels of intracellular ATP drop. Similar
to intracellular ATP, other magnesium nucleotides
can modulate KATP channel activity, with the most
dramatic effects being caused by MgADP, which
antagonizes the inhibitory effects of ATP (1, 9). Our
recent electrophysiological results suggested that
application of intracellular MgADP enhances the in-
hibitory effects of ketamine racemate on the activity
of reconstituted KATP channels expressed in COS-7
cells (8). We therefore hypothesised that intracel-
lular MgADP also may enhance the inhibitory ef-
fects of ketamine racemate on nicorandil induced
KATP channel activities. Surprisingly, our results dem-
onstrated that the inhibitory effect of ketamine ra-
cemate at a clinically relevant concentration (30 μM)
on nicorandil induced KATP channel activities was
almost completely abolished by application of intra-
cellular MgADP. These data suggest that the thera-
peutic effectiveness of nicorandil might not be im-
paired by ketamine racemate under metabolic stress
conditions. The exact mechanisms of these effects
have not been clearly identified. A recent study,
however, indicated that metabolic inhibition signifi-
cantly increased the potency of nicorandil on pig
coronary artery relaxation (20). These results sug-
gest that MgADP may enhance nicorandil induced
KATP channel activities. Thus, our results suggest
that the MgADP enhancement of KATP channel ac-
tivation of nicorandil could mask the inhibitory ef-
fects of ketamine racemate.
The inherent limitations of this study model must
be addressed. First, the concentration of nicorandil
we used in the current study (100 μM) should be
much higher than the clinically relevant concentra-
tions (approximately 1 μM) (21). Therefore, it may
be difficult to directly extrapolate our results to in
vivo conditions. Second, we performed patch clamp
experiments in cultured, not freshly isolated, VSMCs
to avoid using damaged cells. Although cultured
cells may undergo a variety of phenotypic changes,
the functions of vascular KATP channels (e.g. sensi-
tivity of KATP channel modulators and single channel
conductance) were consistent with those of KATP
channels previously recorded in freshly isolated
VSMCs (22).
In conclusion, our results demonstrated that keta-
mine inhibits nicorandil induced vascular KATP chan-
nels activity in a dose-dependent and stereoselec-
tive manner. However, our results further indicated
that increase of intracellular MgADP markedly at-
tenuated the inhibitory effect of ketamine. These
results suggested the possibility that ketamine might
not impair the beneficial vasodilative effects of ni-
corandil as a KATP channel opener under conditions
of metabolic inhibition.
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